Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 4
Submit an article Journal homepage
69
Views
6
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes

Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Peter P. Toth Sterling Rock Falls Clinic, Sterling, ILCorrespondence[email protected]
, MD, PhD
Pages 46-53 | Published online: 13 Mar 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marc Rendell, Andjela Drincic & Radha Andukuri. (2012) Alogliptin benzoate for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 13:4, pages 553-563.
Read now

Articles from other publishers (5)

Heli Siti Halimatul Munawaroh, Gun Gun Gumilar, Jerlita Dea Berliana, Siti Aisyah, Vidia Afina Nuraini, Andriati Ningrum, Eko Susanto, Larasati Martha, Isman Kurniawan, Nur Akmalia Hidayati, Apurav Krishna Koyande & Pau-Loke Show. (2022) In silico proteolysis and molecular interaction of tilapia (Oreochromis niloticus) skin collagen-derived peptides for environmental remediation. Environmental Research 212, pages 113002.
Crossref
Heli Siti Halimatul Munawaroh, Farah Hazmatulhaq, Gun Gun Gumilar, Riska Nur Pratiwi, Isman Kurniawan, Andriati Ningrum, Nur Akmalia Hidayati, Apurav Krishna Koyande, P. Senthil Kumar & Pau-Loke Show. (2022) Microalgae as a potential sustainable solution to environment health. Chemosphere 295, pages 133740.
Crossref
R. E. Zambrana, L. Lopez, G. Y. Dinwiddie, R. M. Ray, L. S. Phillips, M. Trevisan & S. Wassertheil-Smoller. (2014) Prevalence and Incident Prehypertension and Hypertension in Postmenopausal Hispanic Women: Results from the Women's Health Initiative. American Journal of Hypertension 27:3, pages 372-381.
Crossref
LIONEL H. OPIE & JURIS MEIER. 2013. Drugs for the Heart. Drugs for the Heart 436 462 .
Janet B. McGill. (2012) Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials. Therapeutic Advances in Endocrinology and Metabolism 3:4, pages 113-124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.